Procter & Gamble Hygiene and Health Care Limited has informed the Exchange regarding a press release dated May 28, 2026, titled "Press Release for the quarter and financial year ended March 31, 2026".
PGHH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
P&G Hygiene and Health Care reported FY2026 sales of ₹4,290 crore, essentially flat versus the prior year. Profit After Tax (PAT) grew 19% to ₹857 crore, supported by product mix, productivity and efficiency improvements. For Q4 FY2026, sales declined 5% to ₹941 crore and PAT fell 2% to ₹153 crore. The company changed its financial year from July–June to April–March, so comparisons are made against a full 12-month prior period. The Board has recommended a final dividend of ₹60 per share, bringing the total dividend payout (including interim) to ₹255 per share, subject to shareholder approval.
Steady bottom-line growth with flat to declining top line indicates margin improvement and cost efficiency. The Q4 revenue decline may raise near-term concerns but the full-year PAT growth of 19% signals operational resilience.